Psychedelic Stocks Icon

Psychedelic Stocks

Psychedelics, such as psilocybin and DMT, are a class of powerful psychoactive substances that affect mood and cognitive processes. While still federally illegal under U.S. law, some states have voted to partially decriminalize the substances. Meanwhile, companies like ATAI Life Sciences and Compass Pathways have taken the initiative of developing psychedelic drugs to treat disorders like PTSD and depression.

A handful of brightly colored pills in different shapes and sizes is scattered on a turquoise background.

3 Next-Gen Drug Stocks Exploring Psychedelic Frontiers

These psychedelic drug stocks aren't as radical as once thought as institutional awareness and emphasize on their potential increases.

A handful of brightly colored pills in different shapes and sizes is scattered on a turquoise background.

Psychedelic Picks: 3 Trippy Stocks Aiming for Out-of-This-World Returns

Psychedelics could be a game-changer in treating mental health issues, creating substantial opportunities for top psychedelic stocks.

Hand holding a smartphone with the text of buy the dip in, stock market correction. "It's dip o'clock!" famous sentence. Economics, Stock Market, Stock Exchange, Background. 3D illustration.

3 Biotech Stocks to Buy on the Dip: May 2024

These biotech giants offer investors the best opportunity money can buy for excellent profits and returns this year.

Other industries you might be interested in

Marijuana leaf

Cannabis

Cross symbol representing healthcare

Healthcare

Icon depicting a DNA strand

Biotech

Recent Psychedelic Stocks Articles

Why Is Clearmind Medicine (CMND) Stock Up 47% Today?

By William White, InvestorPlace Writer
Clearmind Medicine (CMND) stock is on the rise with heavy trading Wednesday despite a lack of news from the psychedelic medicines company.

Why Is Mind Medicine (MNMD) Stock Up 26% Today?

By William White, InvestorPlace Writer
Mind Medicine (MNMD) stock is on the rise Friday after releasing positive results from a Phase 2 clinical trial of lysergide (LSD).

Why Is Clearmind Medicine (CMND) Stock Up 56% Today?

By William White, InvestorPlace Writer
Clearmind Medicine (CMND) stock is taking off on Tuesday with heavy trading despite a lack of news concerning the psychedelics company.

7 Cannabis Stocks That Can Make You a Millionaire as Legalization Spreads

By Ian Cooper, InvestorPlace Contributor
Cannabis stocks could see higher highs with several key catalysts, creating a potential $100 billion opportunity.

The 7 Most Promising Psychedelic Stocks to Buy in February

By Muslim Farooque, InvestorPlace Contributor
These psychedelics stocks to buy belong to pre-revenue firms which could potentially blow-up in line with the burgeoning sector.

The 3 Best Sectors to Invest in for 2023

By Alex Sirois, InvestorPlace Contributor
A blend of value and growth defines the best sectors to invest in for 2023. These three sectors best fit the definition.

7 Psychedelics Stocks to Buy for a Big Drug Boom

By Tezcan Gecgil, InvestorPlace Contributor
These are the seven psychedelics stocks to buy in September. PSIL, ATAI, CMPS, CYBN, ENVB, GHRS and MNMD can make great investments

3 Best Psychedelic Stocks to Buy Now

By Muslim Farooque, InvestorPlace Contributor
These are three of the best psychedelic stocks to buy to get in on the next generation of treatment for mental health disorders.
Load More Articles